Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
11.05
+0.55 (5.24%)
At close: Mar 27, 2024, 4:00 PM
10.97
-0.08 (-0.72%)
Pre-market: Mar 28, 2024, 4:26 AM EDT

Phathom Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
384.26155.89183.42287.5243.770.88
Cash & Cash Equivalents
384.26155.89183.42287.5243.770.88
Cash Growth
146.49%-15.01%-36.20%17.94%27632.08%-
Receivables
1.6400000
Inventory
9.4400000
Other Current Assets
2.14.623.113.8711.840.02
Total Current Assets
397.43160.51186.53291.37255.60.9
Property, Plant & Equipment
3.623.492.563.361.40
Other Long-Term Assets
12.790.80.340.380.180
Total Long-Term Assets
16.414.32.913.741.580
Total Assets
413.84164.81189.43295.11257.180.9
Accounts Payable
12.6105.1516.780.70.06
Current Debt
0.730.710.497.830.161.95
Other Current Liabilities
25.4515.5313.2830.922.890.18
Total Current Liabilities
38.7826.2418.9255.523.752.19
Long-Term Debt
438.12205.8990.8541.1923.410
Other Long-Term Liabilities
9.77.57.54.132.060
Total Long-Term Liabilities
447.82213.3998.3545.3225.480
Total Liabilities
486.6239.62117.28100.8429.222.19
Total Debt
438.85206.691.3449.0223.571.95
Debt Growth
112.42%126.18%86.34%107.94%1108.87%-
Retained Earnings
-928.69-727.09-529.37-385.49-256.42-1.29
Shareholders' Equity
-72.76-74.8172.16194.27227.96-1.29
Net Cash / Debt
-54.59-50.7192.08238.48220.19-1.07
Net Cash / Debt Growth
---61.39%8.30%--
Net Cash Per Share
-1.06-1.302.497.1819.37-0.18
Working Capital
358.65134.28167.61235.84251.85-1.29
Book Value Per Share
-1.42-1.911.955.8520.05-0.21
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).